Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Immunization”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Not applicableStudy completedNCT04665791
What this trial is testing

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Who this might be right for
Meningitis, Meningococcal
Center for Vaccine Development - Mali 55
Large-scale testing (Phase 3)Study completedNCT00974363
What this trial is testing

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 697
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Not applicableLooking for participantsNCT07379151
What this trial is testing

Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

Who this might be right for
Meningoccocal Disease
Serum Institute of India Pvt. Ltd. 450
Post-approval studies (Phase 4)Study completedNCT00310713
What this trial is testing

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 33
Testing effectiveness (Phase 2)Study completedNCT00715910
What this trial is testing

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 818
Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Study completedNCT00390143
What this trial is testing

Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 46
Post-approval studies (Phase 4)Study completedNCT03125616
What this trial is testing

Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

Who this might be right for
PrematurityVaccinationMeningococcal Disease
St George's, University of London 136
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Post-approval studies (Phase 4)Study completedNCT00392808
What this trial is testing

Immunogenicity of the Booster Dose of Two MenC Vaccines

Who this might be right for
Meningococcal Infection
Centro Superior de Investigación en Salud Publica 389
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647407
What this trial is testing

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 750
Large-scale testing (Phase 3)Study completedNCT04368429
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi 360
Large-scale testing (Phase 3)Study completedNCT00657709
What this trial is testing

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Who this might be right for
Serogroup B Meningococcal Meningitis
Novartis Vaccines 3,630
Large-scale testing (Phase 3)Study completedNCT00955682
What this trial is testing

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 342
Large-scale testing (Phase 3)Study completedNCT01339923
What this trial is testing

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,409
Large-scale testing (Phase 3)Study completedNCT04490018
What this trial is testing

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 463
Large-scale testing (Phase 3)Study completedNCT01148524
What this trial is testing

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 817
Post-approval studies (Phase 4)Study completedNCT03493919
What this trial is testing

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,021
Testing effectiveness (Phase 2)Study completedNCT00721396
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,885
Next Page